Healthcare provider profile · identity verified

John Christopher Shaw, MD

Internal Medicine · LONGVIEW, WA · NPI 1528175239

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	967	295
Amlodipine Besylate	Amlodipine Besylate	561	165
Lisinopril	Lisinopril	513	165
Losartan Potassium	Losartan Potassium	460	152
Levothyroxine Sodium	Levothyroxine Sodium	395	107
Metoprolol Succinate	Metoprolol Succinate	290	105
Albuterol Sulfate Hfa	Albuterol Sulfate	251	93
Metoprolol Tartrate	Metoprolol Tartrate	244	78
Potassium Chloride	Potassium Chloride	228	80
Gabapentin	Gabapentin	216	62
Metformin Hcl	Metformin Hcl	214	69
Tamsulosin Hcl	Tamsulosin Hcl	195	66
Furosemide	Furosemide	194	68
Hydrochlorothiazide	Hydrochlorothiazide	182	56
Glipizide	Glipizide	180	61
Trazodone Hcl	Trazodone Hcl	172	51
Simvastatin	Simvastatin	168	48
Pantoprazole Sodium	Pantoprazole Sodium	156	55
Pradaxa	Dabigatran Etexilate Mesylate	146	50
Rosuvastatin Calcium	Rosuvastatin Calcium	121	39
Allopurinol	Allopurinol	119	33
Omeprazole	Omeprazole	113	37
Atenolol	Atenolol	104	28
Oxycodone Hcl	Oxycodone Hcl	104	22
Sertraline Hcl	Sertraline Hcl	104	37
Warfarin Sodium	Warfarin Sodium	103	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	97	29
Fluoxetine Hcl	Fluoxetine Hcl	95	32
Metformin Hcl Er	Metformin Hcl	89	30
Humulin N	Insulin Nph Human Isophane	86	29
Clopidogrel	Clopidogrel Bisulfate	77	26
Meloxicam	Meloxicam	76	30
Prednisone	Prednisone	76	42
Duloxetine Hcl	Duloxetine Hcl	75	26
Pravastatin Sodium	Pravastatin Sodium	73	23
Alendronate Sodium	Alendronate Sodium	70	34
Ondansetron Odt	Ondansetron	66	17
Wixela Inhub	Fluticasone Propion/Salmeterol	61	19
Jardiance	Empagliflozin	60	23
Alvesco	Ciclesonide	55	24
Finasteride	Finasteride	55	17
Buspirone Hcl	Buspirone Hcl	50	suppressed
Spironolactone	Spironolactone	50	16
Terazosin Hcl	Terazosin Hcl	49	14
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	48	20
Isosorbide Mononitrate Er	Isosorbide Mononitrate	47	18
Triamcinolone Acetonide	Triamcinolone Acetonide	47	25
Spiriva Respimat	Tiotropium Bromide	45	15
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	43	16
Nitroglycerin	Nitroglycerin	43	25
Humulin R	Insulin Regular, Human	40	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	11
Mirtazapine	Mirtazapine	40	16
Carvedilol	Carvedilol	39	14
Ropinirole Hcl	Ropinirole Hcl	39	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	13
Torsemide	Torsemide	38	15
Eliquis	Apixaban	37	11
Morphine Sulfate Er	Morphine Sulfate	37	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	13
Doxycycline Monohydrate	Doxycycline Monohydrate	36	29
Lorazepam	Lorazepam	35	13
Nystatin	Nystatin	35	14
Ozempic	Semaglutide	35	suppressed
Pregabalin	Pregabalin	35	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	35	suppressed
Acyclovir	Acyclovir	33	13
Shingrix	Varicella-Zoster Ge/As01b/Pf	33	30
Humalog Kwikpen U-100	Insulin Lispro	32	suppressed
Montelukast Sodium	Montelukast Sodium	30	12
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	23
Donepezil Hcl	Donepezil Hcl	27	suppressed
Famotidine	Famotidine	26	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	25	suppressed
Sucralfate	Sucralfate	25	suppressed
Bupropion Xl	Bupropion Hcl	24	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Clonazepam	Clonazepam	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	22	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Tramadol Hcl	Tramadol Hcl	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Topiramate	Topiramate	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	16
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	19	suppressed
Ketoconazole	Ketoconazole	19	13
Memantine Hcl	Memantine Hcl	19	suppressed
Naproxen	Naproxen	19	suppressed
Digoxin	Digoxin	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Baclofen	Baclofen	17	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Estradiol	Estradiol	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	17	suppressed
Valsartan	Valsartan	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Creon	Lipase/Protease/Amylase	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Veo Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	14	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	13	13
Aripiprazole	Aripiprazole	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Trospium Chloride	Trospium Chloride	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	12	suppressed
Cephalexin	Cephalexin	12	11
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Epinephrine	Epinephrine	12	suppressed
Fluticasone Propionate	Fluticasone Propionate	12	suppressed
Lactulose	Lactulose	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Cefadroxil	Cefadroxil	11	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error